My answers below
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Tibi-Scherl, Leila
Sent: Monday, June 20, 2016 10:48 AM
To: 'nyschp.dop@xxxxxxxxxxxxx'
Subject: [nyschp.dop] GP2B3A inhibitors & Stress Test Agents
Good morning, all,
A member hospital would like feedback on your practices with GP2B3A inhibitors
and Stress Test Agents. Please respond YES or NO to the following two short
questions:
Is your hospital using to Aggrastat as the primary glycoprotein 2b/3a inhibitor
(as compared to Integrilin)? No
Is your hospital using Lexiscan as the primary nuclear stress test agent? Yes
Your time is greatly appreciated. Thank you in advance for taking the time to
respond!
Sincerely,
Leila
--
Leila M. Tibi-Scherl, Pharm.D.
VP, Pharmacy Practice
GNYHA Services, Inc. | 555 W. 57th Street, Suite 1156 | New York, NY 10019
* 212.259.0775 |È646.483.3333 |7 212.541.9032 |*
tibi@xxxxxxxxx<mailto:tibi@xxxxxxxxx>
www.pharmacy.gnyhaservices.com<http://www.pharmacy.gnyhaservices.com/>
PQ Please consider the environment before printing this email.
This message and any attachments are confidential and intended solely
for the use of the individual or entity to which they are addressed. If
you are not the intended recipient, you are prohibited from printing,
copying, forwarding, saving, or otherwise using or relying upon them in
any manner. Please notify the sender immediately if you have received
this message by mistake and delete it from your system.
